{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:11:00Z","timestamp":1778490660193,"version":"3.51.4"},"reference-count":33,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    A new micellar electrokinetic capillary chromatographic (MEKC) method has been developed and optimized for simultaneous quantitation of doxorubicin (Dox) and fullerenol (Frl) in rat serum. The separation was carried out in a capillary (48.5\u201340 cm to the detector \u2013 50 \u00b5m id fused-silica capillary with bubble cell, 150 \u00b5m) at an applied voltage of 25 kV and temperature of 25 \u00b0C. For the background electrolyte 10 mmol L\n                    <jats:sup>\u2013<\/jats:sup>\n                    <jats:sup>1<\/jats:sup>\n                    borate buffer pH 9.3 plus 15 mmol L\u20131 phosphate buffer pH 7.0 (with the final pH of the mixture adjusted to 7.0 with HCl), with added 10 % (\n                    <jats:italic>V<\/jats:italic>\n                    \/\n                    <jats:italic>V<\/jats:italic>\n                    ) methanol, and 15 mmol L\u20131 sodium dodecyl sulfate as a surfactant, were used. The hydrodynamic injection was carried out at 5.0 kPa during the period of 100 s. Linear calibration curves were established over the concentration range 0.5\u2013500.0 mg L\n                    <jats:sup>\u2013<\/jats:sup>\n                    <jats:sup>1<\/jats:sup>\n                    for Dox and 10.0\u2013500.0 mg L\n                    <jats:sup>\u2013<\/jats:sup>\n                    <jats:sup>1<\/jats:sup>\n                    for Frl (at 234 nm). The proposed MEKC procedure was fully validated and applied for the deter mination of Dox and Frl in Wistar rats after intra pe ritoneal administration of both molecules.\n                  <\/jats:p>","DOI":"10.2478\/acph-2024-0026","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T04:08:33Z","timestamp":1726459713000},"page":"495-509","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of doxorubicin and fullerenol in rat serum by micellar electrokinetic capillary chromatography"],"prefix":"10.2478","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6563-0922","authenticated-orcid":false,"given":"Rade","family":"Injac","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Chair of Pharmaceutical Biology , University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7096-672X","authenticated-orcid":false,"given":"Miranda","family":"Serti\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy and Biochemistry Department of Pharmaceutical Analysis , University of Zagreb , Zagreb Croatia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6289-8309","authenticated-orcid":false,"given":"Nina Ko\u010devar","family":"Glava\u010d","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Chair of Pharmaceutical Biology , University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2024,9,14]]},"reference":[{"key":"2026051108204765665_j_acph-2024-0026_ref_001","doi-asserted-by":"crossref","unstructured":"R. Injac and B. Strukelj, Recent advances in protection against doxorubicin-induced toxicity, Technol. Cancer Res. Treat. 7 (2008) 497\u2013516; https:\/\/doi.org\/10.1177\/153303460800700611","DOI":"10.1177\/153303460800700611"},{"key":"2026051108204765665_j_acph-2024-0026_ref_002","doi-asserted-by":"crossref","unstructured":"C. Carvalho, R. X. Santos, S. Cardoso, S. Correia, P. J. Oliveira, M. S. Santos and P. I. Moreira, Doxorubicin: The good, the bad and the ugly effect, Curr. Med. Chem. 16(25) (2009) 3267\u20133285; https:\/\/doi.org\/10.2174\/092986709788803312","DOI":"10.2174\/092986709788803312"},{"key":"2026051108204765665_j_acph-2024-0026_ref_003","doi-asserted-by":"crossref","unstructured":"R. Injac, Potential medical use of fullerenols after two decades of oncology research, Technol. Cancer Res. Treat. 22 (2023) 1\u201321; https:\/\/doi.org\/10.1177\/15330338231201515","DOI":"10.1177\/15330338231201515"},{"key":"2026051108204765665_j_acph-2024-0026_ref_004","doi-asserted-by":"crossref","unstructured":"R. Injac, M. Perse, N. Obermajer, V. Djordjevic-Milic, M. Prijatelj, A. Djordjevic, A. Cerar, and B. Strukelj, Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas, Biomaterials 29(24\u201325) (2008) 3451\u20133460; https:\/\/doi.org\/10.1016\/j.biomaterials.2008.04.048","DOI":"10.1016\/j.biomaterials.2008.04.048"},{"key":"2026051108204765665_j_acph-2024-0026_ref_005","doi-asserted-by":"crossref","unstructured":"R. Injac, M. Perse, M. Cerne, N. Potocnik, N. Radic, B. Govedarica, A. Djordjevic, A. Cerar and B. Strukelj, Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer, Biomaterials 30(6) (2009) 1184\u20131196; https:\/\/doi.org\/10.1016\/j.biomaterials.2008.10.060","DOI":"10.1016\/j.biomaterials.2008.10.060"},{"key":"2026051108204765665_j_acph-2024-0026_ref_006","doi-asserted-by":"crossref","unstructured":"R. Injac, M. Perse, M. Boskovic, V. Djordjevic-Milic, A. Djordjevic, A. Hvala, A. Cerar and B. Strukelj, Cardioprotective effects of fullerenol C60(OH)24 on a single dose doxorubicin induced cardiotoxicity in rats with malignant neoplasm, Technol. Cancer Res. Treat. 7(1) (2008) 15\u201326; https:\/\/doi.org\/10.1177\/153303460800700102","DOI":"10.1177\/153303460800700102"},{"key":"2026051108204765665_j_acph-2024-0026_ref_007","doi-asserted-by":"crossref","unstructured":"Z. Zhang, Y. Zhang, S. Song, L. Yin, D. Sun and J. Gu, Recent advances in the bioanalytical methods of polyethylene glycols and PEGylated pharmaceuticals, J. Sep. Sci. 43(9\u201310) (2020) 1978\u20131997; https:\/\/doi.org\/10.1002\/jssc.201901340","DOI":"10.1002\/jssc.201901340"},{"key":"2026051108204765665_j_acph-2024-0026_ref_008","doi-asserted-by":"crossref","unstructured":"Y. Xiao, Y. Wanxiang, H. Xiufen, C. Zuanguang, W. Shumei and Z. Haiyun, Sensitive analysis of doxorubicin and curcumin by micellar electromagnetic chromatography with a double wavelength excitation source, Anal. Bioanal. Chem. 413 (2021) 469\u2013478; https:\/\/doi.org\/10.1007\/s00216-020-03017-5","DOI":"10.1007\/s00216-020-03017-5"},{"key":"2026051108204765665_j_acph-2024-0026_ref_009","doi-asserted-by":"crossref","unstructured":"S. M. Ansar and T. Mudalige, Direct and simultaneous determination of intra-liposomal and external sulfate in liposomal doxorubicin formulations by capillary electrophoresis\/inductively coupled plasma-tandem mass spectrometry (CE\/ICP-MS\/MS), Int. J. Pharm. 561 (2019) 283\u2013288; https:\/\/doi.org\/10.1016\/j.ijpharm.2019.03.003","DOI":"10.1016\/j.ijpharm.2019.03.003"},{"key":"2026051108204765665_j_acph-2024-0026_ref_010","doi-asserted-by":"crossref","unstructured":"M. Alizadeh, M. Hasanzadeh, J. Soleymani, J. V. Gharamaleki and A. Jouyban, Application of bioactive cyclic oligosaccharide on the detection of doxorubicin hydrochloride in unprocessed human plasma sample: A new platform towards efficient chemotherapy, Microchem. J. 145 (2019) 450\u2013455; https:\/\/doi.org\/10.1016\/j.microc.2018.11.012","DOI":"10.1016\/j.microc.2018.11.012"},{"key":"2026051108204765665_j_acph-2024-0026_ref_011","doi-asserted-by":"crossref","unstructured":"J. A. Ho, N. Fan, A. F. Jou, L. Wu and T. Sun, Monitoring the subcellular localization of doxorubicin in CHO-K1 using MEKC-LIF: Liposomal carrier for enhanced drug delivery, Talanta 99 (2012) 683\u2013688; https:\/\/doi.org\/10.1016\/j.talanta.2012.06.077","DOI":"10.1016\/j.talanta.2012.06.077"},{"key":"2026051108204765665_j_acph-2024-0026_ref_012","doi-asserted-by":"crossref","unstructured":"N. Guichard, M. Ogereau, L. Falaschi, S. Rudaz, J. Schappler, P. Bonnabry and S. Fleury-Souverain, Determination of 16 antineoplastic drugs by capillary electrophoresis with UV detection: Applications in quality control, Electrophoresis 39(20) (2018) 2512\u20132520; https:\/\/doi.org\/10.1002\/elps.201800007","DOI":"10.1002\/elps.201800007"},{"key":"2026051108204765665_j_acph-2024-0026_ref_013","doi-asserted-by":"crossref","unstructured":"J. Mbuna and T. Kaneta, Capillary electrophoresis with laser-induced fluorescence detection for application in intracellular investigation of anthracyclines and multidrug resistance proteins, Anal. Sci. 31 (2015) 1121\u20131128; https:\/\/doi.org\/10.2116\/analsci.31.1121","DOI":"10.2116\/analsci.31.1121"},{"key":"2026051108204765665_j_acph-2024-0026_ref_014","doi-asserted-by":"crossref","unstructured":"Y. Shakalisava and F. Regan, CE separation approaches for combinations of anthracyclines and taxanes, Electrophoresis 30(17) (2009) 3110\u20133113; https:\/\/doi.org\/10.1002\/elps.200900097","DOI":"10.1002\/elps.200900097"},{"key":"2026051108204765665_j_acph-2024-0026_ref_015","doi-asserted-by":"crossref","unstructured":"N. Kishikawa and N. Kuroda, Analytical techniques for the determination of biologically active quinones in biological and environmental samples, J. Pharm. Biomed. Anal. 87 (2014) 261\u2013270; https:\/\/doi.org\/10.1016\/j.jpba.2013.05.035","DOI":"10.1016\/j.jpba.2013.05.035"},{"key":"2026051108204765665_j_acph-2024-0026_ref_016","doi-asserted-by":"crossref","unstructured":"C. L. Flurer, Analysis of antibiotics by capillary electrophoresis, Electrophoresis 24(22-23) (2003) 4116\u20134127; https:\/\/doi.org\/10.1002\/elps.200305639","DOI":"10.1002\/elps.200305639"},{"key":"2026051108204765665_j_acph-2024-0026_ref_017","doi-asserted-by":"crossref","unstructured":"G. Zagotto, B. Gatto, S. Moro, C. Sissi and M. Palumbo, Anthracyclines: recent developments in their separation and quantitation, J. Chromatogr. B 764(1-2) (2001) 161\u2013171; https:\/\/doi.org\/10.1016\/s0378-4347(01)00346-2","DOI":"10.1016\/S0378-4347(01)00346-2"},{"key":"2026051108204765665_j_acph-2024-0026_ref_018","doi-asserted-by":"crossref","unstructured":"K. E. Maudensa, C. P. Stove and W. E. Lambert, Quantitative liquid chromatographic analysis of anthracyclines in biological fluids, J. Chromatogr. B 879(25) (2011) 2471\u20132486; https:\/\/doi.org\/10.1016\/j.jchromb.2011.07.010","DOI":"10.1016\/j.jchromb.2011.07.010"},{"key":"2026051108204765665_j_acph-2024-0026_ref_019","doi-asserted-by":"crossref","unstructured":"E. Koziolova, O. Janouskova, P. Chytil, M. Studenovsky, L. Kostka and T. Etrych, Nanotherapeutics with anthracyclines: methods of determination and quantification of anthracyclines in biological samples, Physiol. Res. 64 (2015) S1-S10; https:\/\/doi.org\/10.33549\/physiolres.933140","DOI":"10.33549\/physiolres.933140"},{"key":"2026051108204765665_j_acph-2024-0026_ref_020","doi-asserted-by":"crossref","unstructured":"P. M. Loadman and C. R. Calabrese, Separation methods for anthraquinone related anti-cancer drugs, J. Chromatogr. B 764(1-2) (2001) 193\u2013206; https:\/\/doi.org\/10.1016\/s0378-4347(01)00281-x","DOI":"10.1016\/S0378-4347(01)00281-X"},{"key":"2026051108204765665_j_acph-2024-0026_ref_021","doi-asserted-by":"crossref","unstructured":"L. Xiao-Pan, S. Wen-Qian, L. Tong-Xin, L. Bing-Bing and C. Chang-Po, Fullerenol as a water-soluble MALDI-MS matrix for rapid analysis of small molecules and efficient quantification of saccharin sodium in foods, J. Chromatogr. B 1178 (2021) Article ID 122819; https:\/\/doi.org\/10.1016\/j.jchromb.2021.122819","DOI":"10.1016\/j.jchromb.2021.122819"},{"key":"2026051108204765665_j_acph-2024-0026_ref_022","doi-asserted-by":"crossref","unstructured":"H. H\u00e4rm\u00e4, S. Laakso, S. Pihlasalo and P. H\u00e4nninen, A fluorometric fullerenol sensor for rapid detection of ionic and non-ionic surfactants, Tenside Surfact. Det. 47 (2010) 40\u201342; https:\/\/doi.org\/10.3139\/113.110052","DOI":"10.3139\/113.110052"},{"key":"2026051108204765665_j_acph-2024-0026_ref_023","doi-asserted-by":"crossref","unstructured":"F. N. Tomilin, P. V. Artyushenko, I. A. Shchugoreva, A. V. Rogova, N. G. Vnukova, G. N. Churilov, N. P. Shestakov, O. N. Tchaikovskaya, S. G. Ovchinnikov and P. V. Avramov, Structure and vibrational spectroscopy of C82 fullerenol valent isomers: An experimental and theoretical joint study, Molecules 28(4) (2023) Article ID 1569 (11 pages); https:\/\/doi.org\/10.3390\/molecules28041569","DOI":"10.3390\/molecules28041569"},{"key":"2026051108204765665_j_acph-2024-0026_ref_024","unstructured":"United States Pharmacopeia, 43th Ed., National Formulary, 38th Ed., USP Convention, Rockville (MD), USA, 2020; http:\/\/www.usp.org; last access date October 2022"},{"key":"2026051108204765665_j_acph-2024-0026_ref_025","unstructured":"ICH Q2(R2) Guideline on Validation of Analytical Procedures, Step 5 \u2013 Revision 1, EMA\/CHMP\/ICH, Amsterdam, December 2023; https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ichq2r2-guideline-validation-analytical-procedures-step-5-revision-1_en.pdf; last access date March 2024"},{"key":"2026051108204765665_j_acph-2024-0026_ref_026","doi-asserted-by":"crossref","unstructured":"R. Injac, N. Kocevar and S. Kreft, Precision of micellar electrokinetic capillary chromatography in the determination of seven antibiotics in pharmaceuticals and feedstuffs, Anal. Chim. Acta 594(1) (2007) 119\u2212127; https:\/\/doi.org\/10.1016\/j.aca.2007.05.003","DOI":"10.1016\/j.aca.2007.05.003"},{"key":"2026051108204765665_j_acph-2024-0026_ref_027","doi-asserted-by":"crossref","unstructured":"R. Injac, M. Boskovic, N. Kocevar and T. Vovk, Comparative study of robustness between micellar electrokinetic capillary chromatography and high-performance liquid chromatography using one-variable-at-a-time and a new multi-variable-at-a-time approach, Anal. Chim. Acta 620(1-2) (2008) 150\u2212161; https:\/\/doi.org\/10.1016\/j.aca.2008.05.007","DOI":"10.1016\/j.aca.2008.05.007"},{"key":"2026051108204765665_j_acph-2024-0026_ref_028","doi-asserted-by":"crossref","unstructured":"M. Kelley and B. DeSilva, Key elements of bioanalytical method validation for macromolecules, AAPS J. 9 (2007) Article ID 17 (E156-E163); https:\/\/doi.org\/10.1208\/aapsj0902017","DOI":"10.1208\/aapsj0902017"},{"key":"2026051108204765665_j_acph-2024-0026_ref_029","doi-asserted-by":"crossref","unstructured":"Z. Wang, X. Chang, Z. Lu, M. Gu, Y. Zhao and X. Gao, A precision structural model for fullerenol, Chem. Sci. 5(8) (2014) 2909-3340; https:\/\/doi.org\/10.1039\/c4sc00584h","DOI":"10.1039\/C4SC00584H"},{"key":"2026051108204765665_j_acph-2024-0026_ref_030","unstructured":"ICH Guideline M10 on Bioanalytical Method Validation and Study Sample Analysis, Step5, EMA\/CHMP\/ ICH, Amsterdam, July 2022; https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf; last access date March 2024"},{"key":"2026051108204765665_j_acph-2024-0026_ref_031","unstructured":"Bioanalytical Method Validation \u2013 Guidance for Industry, FDA\/CDER\/CVM, Silver Spring (MD) and Rockville (MD), USA, May 2018; https:\/\/www.fda.gov\/media\/70858\/download; last access date March 2024"},{"key":"2026051108204765665_j_acph-2024-0026_ref_032","unstructured":"Q2(R2) Validation of Analytical Procedures - Guidance for Industry, FDA\/CDER\/CBER, Silver Spring (MD), USA, March 2024; https:\/\/www.fda.gov\/media\/161201\/download; last access date April 2024"},{"key":"2026051108204765665_j_acph-2024-0026_ref_033","doi-asserted-by":"crossref","unstructured":"J. Methaneethorn, K. Tengcharoen, N. Leelakanok and R. AlEjielat, Population pharmacokinetics of doxorubicin: A systematic review, Asia-Pac. J. Clin. Oncol. 19(1) (2023) 9\u201326; https:\/\/doi.org\/10.1111\/ajco.13776","DOI":"10.1111\/ajco.13776"}],"container-title":["Acta Pharmaceutica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/acph-2024-0026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:42:05Z","timestamp":1778488925000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/acph-2024-0026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9,14]]},"published-print":{"date-parts":[[2024,9,1]]}},"alternative-id":["10.2478\/acph-2024-0026"],"URL":"https:\/\/doi.org\/10.2478\/acph-2024-0026","relation":{},"ISSN":["1846-9558"],"issn-type":[{"value":"1846-9558","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}